论文部分内容阅读
今年在《美国心脏病学会杂志(J Am Coll Cardiol)》上又发表了一篇针对他汀类药物潜在的新发糖尿病风险的研究结果。这项研究(阿托伐他汀治疗期间心血管事件减少与新发糖尿病的比较:基线糖尿病危险因素的影响)针对TNT(Treating to New Targets)试验和IDEAL
This year in the Journal of the American College of Cardiology (J Am Coll Cardiol) published a study of the potential risk of new onset diabetes in statins. The study (Comparison of cardiovascular events reduction with new onset diabetes during atorvastatin treatment: the impact of baseline diabetes risk factors) was conducted for the Treating to New Targets (TNT) trial and IDEAL